Author:
Qari Mohamed,Alshaikh Ahmed,Al-Bukhari Douaa,Al-Ghamdi Buthainah,Al-Ahmadi Raghad,Alsahafi Maryam
Publisher
Discover STM Publishing Ltd.
Reference27 articles.
1. 1. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907-16. https://doi.org/10.1016/S0140-6736(15)60865-0
2. 2. World Health Organization. Worldwide prevalence of anemia 1993-2005. 2008. 2019. Available from: https:// apps.who.int/iris/bitstream/handle/ 10665/43894/9789 241596657_eng. pdf;jsessionid=FA67 CA 3E3 84BFF9 2D7 6949FF7 2E5A928?sequence=1
3. 3. Ikuta K, Shimura A, Terauchi M, Yoshii K, Kawabata Y. Pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in Japanese volunteers with irondeficiency anemia. Int J Hematol. 2018;107(5):519-27. https://doi.org/10.1007/s12185-018-2400-z
4. 4. Bhandari S, Pereira DI, Chappell HF, Drakesmith H. Intravenous irons: from basic science to clinical practice. Pharmaceuticals (Basel). 2018;11(3):82. https://doi. org/10.3390/ph11030082
5. 5. Auerbach M, Macdougall I. The available intravenous iron formulations: history, efficacy, and toxicology. Hemodial Int. 2017;21 (Suppl 1):S83-92. https://doi.org/10.1111/ hdi.12560